Skip to main content

Table 3 Base-case input parameters used in the model

From: Estimating the clinical benefits of vaccinating boys and girls against HPV-related diseases in Europe

Parameter

Values

Vaccine uptake, both sexes

 

  Cumulative percentage of vaccine uptake (first dose) among 12-year olds

70%

Vaccine adherence (probability of second and third dose), both sexes

 

  Percentage of individuals receiving the second dose given first dose

79.7%

  Percentage of individuals receiving the third dose given second dose

63.5%

Duration of protection (years)

lifelong

  1. HPV, human papillomavirus. Values were derived from [17].